# Dae Seog Heo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dae-seog-heo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,427 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 77 |
| i10-index | 351 |
| Last Known Institution | Seoul National University |
| OpenAlex ID | https://openalex.org/A5024891671 |
| ORCID iD | 0000-0001-5221-173X |
| Works | 653 |

## Researcher papers

Showing 12 of 14.

- [Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial](https://scholariq.org/papers/afatinib-versus-placebo-for-patients-with-advanced-metastatic-non-small-cell/)
- [Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-genexol-pm-a-cremophor-free-polymeric/)
- [Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib](https://scholariq.org/papers/predictive-and-prognostic-impact-of-epidermal-growth-factor-receptor-mutation-in/)
- [Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients](https://scholariq.org/papers/elevated-tgf-1-secretion-and-down-modulation-of-nkg2d-underlies-impaired-nk/)
- [Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas](https://scholariq.org/papers/clonal-history-and-genetic-predictors-of-transformation-into-small-cell/)
- [A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer](https://scholariq.org/papers/a-phase-iii-randomized-study-of-5-fluorouracil-and-cisplatin-versus-5/)
- [Validation of the Korean version of the EORTC QLQ-C30](https://scholariq.org/papers/validation-of-the-korean-version-of-the-eortc-qlq-c30/)
- [Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-carboplatin-and-paclitaxel-with/)
- [Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration](https://scholariq.org/papers/pan-cancer-immunogenomic-perspective-on-the-tumor-microenvironment-based-on-pd/)
- [Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/randomized-phase-ii-study-of-dacomitinib-pf-00299804-an-irreversible-pan-human/)
- [Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation](https://scholariq.org/papers/optimization-of-patient-selection-for-gefitinib-in-non-small-cell-lung-cancer-by/)
- [Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial](https://scholariq.org/papers/vandetanib-in-pretreated-patients-with-advanced-non-small-cell-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)

## Researcher university

- [Seoul National University](https://scholariq.org/institutions/seoul-national-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.